
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has demonstrated strong financial performance, achieving record quarterly revenue of $1.7 billion, reflecting a 10% year-over-year increase, primarily driven by exceptional growth in Clearing & Transaction and Market Data revenue. The company's expansion into new markets and asset classes is evidenced by a significant increase in retail traders, with over 90,000 new additions, representing a 56% year-over-year growth, and record international volumes in EMEA and APAC regions, up 15% and 30% respectively. Additionally, the strategic partnerships and acquisitions, including the stakes in S&P Dow Jones Indices and NEX, position CME Group for ongoing revenue growth and enhanced capital efficiency amid favorable market conditions such as rising interest rates.
Bears say
CME Group faces a negative outlook due to the potential for a decline in open interest, which could signal deteriorating market sentiment and negatively impact the company's share performance. The company's heavy dependence on market volumes makes it susceptible to fluctuations in market volatility, especially given the current geopolitical tensions and uncertainty related to tariff impacts that may affect trading activity. Additionally, increased regulatory oversight and competitive pressures could adversely affect revenues and earnings, posing further risks to CME's financial stability.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares